Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability. - Wikidata - awgldk - TriplyDB

Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.

Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.

http://www.wikidata.org/entity/Q34050275

about

Preoperative imatinib treatment in patients with advanced gastrointestinal stromal tumors: patient experiences and systematic review of 563 patients.Duodenal gastrointestinal stromal tumors: clinicopathological characteristics, surgery, and long-term outcome.Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies.Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.Clinicopathological and Prognostic Features of Surgical Management in Duodenal Gastrointestinal Stromal Tumors.Gastrointestinal Stromal Tumors With De Novo Anaplastic Dedifferentiation: Considerations on a Little-Known Neoplastic Metamorphosis.

P2860

Q35676187-C1EEC586-C3E2-412C-AF24-773C962183EF Q35746953-257C310F-AB09-4598-9884-18283DC8D29D Q35862609-A53343C7-EB7F-4205-AEE3-F04DEBF591DE Q41078856-7ABFA079-25F4-4FE3-9051-7D6D7A371BB9 Q41608507-8AC12F02-2687-46A5-83F8-13E693E095D0 Q41691560-E7DC80F9-CC72-4483-8CA6-015682440386 Q47323711-2959F9E6-242B-4052-B404-608E6E1FFB6D Q54380412-8D01242C-C4D1-49CB-A5A8-345E6E9628BF

P2860

Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.

http://www.wikidata.org/entity/Q34050275

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Downsizing treatment with tyro ...... tumors improved resectability.

@ast

Downsizing treatment with tyro ...... tumors improved resectability.

@en

Downsizing treatment with tyro ...... tumors improved resectability.

@nl

type

label

Downsizing treatment with tyro ...... tumors improved resectability.

@ast

Downsizing treatment with tyro ...... tumors improved resectability.

@en

Downsizing treatment with tyro ...... tumors improved resectability.

@nl

prefLabel

Downsizing treatment with tyro ...... tumors improved resectability.

@ast

Downsizing treatment with tyro ...... tumors improved resectability.

@en

Downsizing treatment with tyro ...... tumors improved resectability.

@nl

P1433

Q34050275-8166ED78-A79C-4C7E-AA51-BEEDA20F0656

P1476

Q34050275-0733507F-A129-4741-A05C-3C40592C3A8B

P2093

Q34050275-8527CF69-B308-4B72-A954-662A1D7AEA72

Q34050275-86DB98A8-3AF2-4DBB-B974-FE7BF9C0B52F

Q34050275-BD4432DA-D200-47A8-AFF4-C36EB7E16B9E

Q34050275-DC39A62C-CFCA-4E51-BD98-7787E10369E4

Q34050275-DEE123CC-C444-4958-8A2C-6D5267FB0240

Q34050275-FF95A418-F1DA-4C4D-B545-9A2DD81D72B8

P2860

Q34050275-19C18765-8755-4CCE-8593-2D2239340F59

Q34050275-398FBC6A-4895-4981-9FD4-54ADEFDE57D8

Q34050275-48B1B3C7-EBDD-4B79-AB06-8AF2172B6EC8

Q34050275-49B02556-F683-479A-967C-EBA0677503D0

Q34050275-4A9D6E23-5FD0-4DC7-8D63-36FE9372499D

Q34050275-65E2A909-096B-436C-B23A-7D84EB2CDDA1

Q34050275-6C6601DE-09F2-4298-A326-DADA58977854

Q34050275-78FA5ACF-3DB2-451F-A6CA-CBC6D6DEBE31

Q34050275-7A43DA04-2D1F-4552-8462-192D04E56397

Q34050275-851FECD3-E676-4FD7-A80A-A911EB520789

P2888

Q34050275-BACD718C-E46C-4434-8D69-E62F54B2F0AC

P304

Q34050275-24114BE2-AEE9-49B9-94E0-EEC93E945373

P31

Q34050275-FA1F593F-4087-4F85-B4E5-706B0ACA5026

P356

Q34050275-516BFB29-8F58-4B2D-AFCF-7EC78D571AD4

P433

Q34050275-589A1A85-0AB0-4746-95F6-726660C2C8D0

P478

Q34050275-F83F21C9-D155-4D8A-B266-D60823807686

P577

Q34050275-48C0EA8A-C953-4BA4-8960-43405994632C

P5875

Q34050275-C0912F1D-4623-4BA7-99DD-D9D4C62771DE

P6179

Q34050275-9BE58904-0B2F-473E-83EC-460F15768BDF

P698

Q34050275-51FD0889-683E-480D-9C6C-8F8F4099C4A3

P932

Q34050275-8A1A931F-ED7C-4137-98E2-A0AB1D3719E1

P356

S00268-010-0639-5

P1433

World Journal of Surgery

P1476

Downsizing treatment with tyro ...... tumors improved resectability.

@en

P2093

Anna Andersson

http://www.w3.org/2001/XMLSchema#string

Bengt Nilsson

http://www.w3.org/2001/XMLSchema#string

Erik Nilsson

http://www.w3.org/2001/XMLSchema#string

Håkan Ahlman

http://www.w3.org/2001/XMLSchema#string

Katarina Sjölund

http://www.w3.org/2001/XMLSchema#string

Ola Nilsson

http://www.w3.org/2001/XMLSchema#string

P2860

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate.

Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

P2888

s00268-010-0639-5

P304

2090-2097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00268-010-0639-5

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44639670

http://www.w3.org/2001/XMLSchema#string

P6179

1051353497

http://www.w3.org/2001/XMLSchema#string

P698

20512492

http://www.w3.org/2001/XMLSchema#string

P932

2917560

http://www.w3.org/2001/XMLSchema#string